0 MERS vaccine success in mice suggests potential for COVID-19 vaccine development
A vaccine against MERS has shown promise in mouse models, potentially aiding the development of a vaccine against COVID-19.
Browsing: News
0 Trial drug against COVID-19 shows promise in engineered human tissues
A new study suggests that a human recombinant soluble enzyme blocker, hrsACE2, significantly reduces SARS-CoV-2 viral load in human tissue, suggesting it could have the potential to prevent COVID-19.
0 COVID-19 vaccine candidate shows promise in preclinical research
Researchers from the University of Pittsburgh (PA, USA) have revealed the results from preclinical research testing their COVID-19 vaccine candidate in mice.
0 Thousands of coronavirus cases prevented by China’s control interventions, analysis suggests
It’s a commonly known fact that the current global pandemic caused by the coronavirus originated in Wuhan, China. Over the first 50 days, a series of control measures were implemented to impede the spread, but were these measures effective?
0 Pangolins: the missing link in coronavirus transmission?
There has been much contention regarding how the deadly COVID-19 pandemic originated. The first reported case of the disease was in Wuhan (Hubei province, China). The virus – SARS-CoV-2 – is believed to have been passed from animals to humans, but new data reveals pangolins could be linked to COVID-19 transmission.
0 COVID-19: Updates on vaccines and therapeutics
Take a look at our day-by-day updates covering the latest on therapeutics and vaccines for COVID-19, from new partnerships to clinical trials..
0 COVID-19: First patients dosed in Phase I vaccine trial
Moderna has announced that the first participants have been dosed in a Phase I study of their mRNA candidate vaccine against SARS-CoV-2, the virus that causes COVID-19.
0 Malaria: triple artemisinin-based combination therapies safe and effective
The first clinical trial assessing two triple artemisinin-based combination therapies (TACTs) for treating malaria has suggested these are effective and present no safety concerns.
0 The London patient: long-term follow-up suggests no detectable HIV virus
Long-term follow-up of the ‘London patient’, the second patient to ever achieve sustained HIV remission after ceasing antiretroviral treatment, has suggested that there is no active detectable HIV virus remaining.
0 Is coffee consumption contributing to malaria transmission?
Upon investigating links between the risk of malaria in developing countries and the products demanded by consumers worldwide, researchers have estimated that a significant fraction of the malaria risk in deforestation hotspots is driven by the international trade of products.
